156) en Pb levels and plasma viscosity was not observed. |
157) roxide in the rats treated with AFB1 were observed. |
158) tions on both measures of disability were observed. |
159) ject position, becoming both observer and observed. |
160) use of monitor, keyboard, and chair were observed. |
161) 0%) and erythromycin (92.4-100%) was also observed. |
162) An inflammatory response was also observed. |
163) ) between the study arm and age group was observed. |
164) ermatozoa with normal morphology are also observed. |
165) n of an osteon-like tissue morphology was observed. |
166) les of treatment, tumoral progression was observed. |
167) er and no osteoblasts or osteoclasts were observed. |
168) wo or three pillion riders was also often observed. |
169) ences of Olympic related events were also observed. |
170) For all groups, a bactericidal effect was observed. |
171) ss index, and systolic blood pressure was observed. |
172) sperm with the epididymal epithelium were observed. |
173) e explanatory factors for the differences observed. |
174) ignificant elevation in vagina weight was observed. |
175) fects on risk and protective factors were observed. |
176) atory responses or foreign body reactions observed. |
177) cases, minor variations in morphology are observed. |
178) e control group, a reduction of 92.3% was observed. |
179) No adverse effects of aPDT were observed. |
180) RBC deformability or blood viscosity was observed. |
181) status, haemoglobin levels or anaemia was observed. |
182) n gender-associated diagnostic delays was observed. |
183) als, species or cell passage numbers were observed. |
184) No facial nerve paralysis was observed. |
185) the liver after oral exposure to DZN was observed. |
186) ymorphism or drug-polymer interaction was observed. |
187) ar scar tissue over the defect sites were observed. |
188) regarding pain or oral function could be observed. |
|